
Loading, please wait...

Loading, please wait...

HealthCare Global Enterprises (HCG) recently expanded its medical footprint by launching a comprehensive cancer hospital in Hebbal, Bengaluru. This modern 132-bed facility marks a significant step forward, aiming to deliver advanced oncology care to the region. Specifically, the new center represents an investment of approximately Rs 129 crore, which HCG financed through internal accruals and debt. Consequently, this launch increases HCG's presence to three hospitals within Bengaluru, strengthening its position in India's highly competitive healthcare market.
At the core of the Hebbal facility is the introduction of Karnataka’s first Elekta Unity MR-LINAC. This technology combines high-field MRI imaging with a precise linear accelerator. Consequently, clinicians can achieve real-time, adaptive radiation therapy for diverse cancer types. Moreover, this system adjusts the radiation beam in real-time, which helps spare surrounding healthy tissues. Importantly, patients can now receive highly personalized therapy that adapts to daily changes in tumor shape and position.
Furthermore, the facility houses several advanced therapeutic and diagnostic departments that prioritize optimal patient outcomes. For instance, the center includes five robotic-assisted operation theatres to facilitate minimally invasive procedures. In addition, the infrastructure features 19 chemotherapy daycare beds, 14 premium bays, and a 15-bed intensive care unit. Therefore, local and international patients gain access to full-spectrum cancer services, from diagnosis to recovery support, under one roof.
Historically, this launch follows KKR's acquisition of a 54% stake in HCG for Rs 3,466 crore last year. Currently, HCG operates approximately 2,500 beds across 25 cancer centers in India. Meanwhile, the chain remains in active negotiations to acquire Siemens Healthineers-owned American Oncology. As a result, HCG continues to scale its presence, offering superior clinical expertise and compassionate patient care.
Q1: What is the significance of the MR-LINAC technology at HCG Hebbal?
The Elekta Unity MR-LINAC technology combines high-field MRI imaging with a linear accelerator. Consequently, this allows clinicians to perform highly precise, real-time, adaptive radiation therapy while sparing surrounding healthy tissues.
Q2: How many beds and specialized units does the new HCG facility in Hebbal feature?
The facility features a capacity of 132 beds. Specifically, it includes five robotic-assisted theatres, 19 chemotherapy daycare beds, 14 premium bays, and a 15-bed ICU.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


HCG has launched a new 132-bed comprehensive cancer hospital in Hebbal, Bengaluru, featuring Karnataka's first MR-LINAC technology for precision therapy....
5 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today